This grant is addressed toward several projects relating to neurotransmitter receptors, enzymes involved in neurotransmitter disposition and drug interactions. Three areas are described in detail. One deals with phorbol ester receptors which appear to be identical with protein kinase C. Experimental approaches are proposed to identify a role of protein kinase C in synaptic transmission. Phorbol esters will be used as probes to modify the effects of neurotransmitters upon smooth muscle and to examine the role of lithium. Effects of phorbol esters will be explored upon neurotransmitter release. Autoradiographic and immunocytochemical localization of phorbol ester receptors will also be carried out. A second project deals with the actions of the neurotoxin MPTP (1-mythyl-4-phenyl-1,2,3,6,tetrayhydropyridine). MPTP induces an experimental form of Parkinson's Disease. Detailed autoradiographic maps of MPTP receptor binding sites will be obtained. Strain differences in MPTP disposition will be explored to look for correlations with strain differences in the neurotoxicity of MPTP. The relationship of MPTP binding sites to monoamine oxidase will be examined. A third project deals with calcium antagonist receptors. Different receptor binding sites for diltiazem, verapamil-like drugs and dihydropyridines will be characterized and their inter-relationships explored. Effects of calcium antagonists on synaptosomal calcium flux will be examined and interactions among calcium antagonists of different classes upon calcium flux will be evaluated. A relationship of adenylate cyclase to synaptosomal calcium flux will also be examined.
Paul, Bindu D; Sbodio, Juan I; Snyder, Solomon H (2018) Cysteine Metabolism in Neuronal Redox Homeostasis. Trends Pharmacol Sci 39:513-524 |
Kornberg, Michael D; Bhargava, Pavan; Kim, Paul M et al. (2018) Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360:449-453 |
Sbodio, Juan I; Snyder, Solomon H; Paul, Bindu D (2018) Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington's disease. Proc Natl Acad Sci U S A 115:780-785 |
Paul, Bindu D; Snyder, Solomon H (2018) Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol 149:101-109 |
Kornberg, Michael D; Smith, Matthew D; Shirazi, Hasti Atashi et al. (2018) Bryostatin-1 alleviates experimental multiple sclerosis. Proc Natl Acad Sci U S A 115:2186-2191 |
Fu, Chenglai; Tyagi, Richa; Chin, Alfred C et al. (2018) Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1? Degradation. Circ Res 122:457-472 |
Harraz, Maged M; Snyder, Solomon H (2017) Antidepressant Actions of Ketamine Mediated by the Mechanistic Target of Rapamycin, Nitric Oxide, and Rheb. Neurotherapeutics 14:728-733 |
Peng, Ying-Jie; Zhang, Xiuli; Gridina, Anna et al. (2017) Complementary roles of gasotransmitters CO and H2S in sleep apnea. Proc Natl Acad Sci U S A 114:1413-1418 |
Sbodio, Juan I; Snyder, Solomon H; Paul, Bindu D (2016) Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease. Proc Natl Acad Sci U S A 113:8843-8 |
Kim, Hyo Jung; Cha, Jiyoung Y; Seok, Jo Woon et al. (2016) Dexras1 links glucocorticoids to insulin-like growth factor-1 signaling in adipogenesis. Sci Rep 6:28648 |
Showing the most recent 10 out of 58 publications